Cannabis Earnings

This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More

Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap

Red Light Holland Q2 Revenue Up 39.1% YoY, Cuts Net Loss Thanks To 'Strong Financial Discipline'

Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap

Red Light Holland Q2 Revenue Up 39.1% YoY, Cuts Net Loss Thanks To 'Strong Financial Discipline'

Canadian Cannabis Producer Red White & Bloom Narrows Q3 Net Loss As Revenue Stays Flat YoY

PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025

Canadian Cannabis Producer Red White & Bloom Narrows Q3 Net Loss As Revenue Stays Flat YoY

PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025

Ayurcann Cannabis Co. Reports 28% YoY Net Revenue Growth In Q1 With Strong Performance In Vapes And Pre-Rolls

Canadian Cannabis Co. Entourage Health Shares Spike On 8% YoY Q3 Revenue Growth, Reduced Losses

Cannabis Earnings Recent News

Cannabis-Focused RIV Capital Reports 186% YoY Surge In Q3 Revenue Ahead Of Major Merger That Will Cover 25% Of US Population

RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) reported on Friday its third quarter results for the three months ended Sept. 30, revealing a 28% sequential and 186% increase year-over-year in net revenue to $4.9 million.Out of that sum, retail revenue accounted for $3.4 million, up from $1.5 million in the third quarter, reflecting strong growth from adult-use dispensaries in New York. Wholesale revenue surged to $1.6 million, up from $0.3 million over the same period, the company said in a press release.

Greenway Greenhouse Cannabis Sees 52% YoY Growth In Q2 Revenue Amid Rising Losses And Cost Challenges

Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) reported on Wednesday its second-quarter interim financial statements for the three months ended Sept. 30, 2024. Canadian cultivator of high-quality greenhouse cannabis reported a 52% year-over-year increase in revenue to CA$1.8 million ($1.3 million). Moreover, for the first half of the fiscal year, Greenway's net revenue increased by 78% compared to the same period in 2023.CEO Jamie D'Alimonte highlighted the company's revenue growth, product performance and ongoing commitment to quality cannabis production in a press release issued Wednesday.

Cannabis Fintech POSaBIT Systems Q3 Revenue Plunges Amid Temporary Processing Disruptions, But Gross Profit Margins Surge

Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability

Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended Aug. 31. The Montreal, Canada-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2 million ($58.8 million). Gross profit for the full year grew by 32% over the same period, reaching CA$27.9 million, with a gross margin of 34% before fair value adjustments. Positive operating cash flow increased by 81% to CA$10.7 million, while free cash flow turned positive at CA$3.2 million, a CA$7.2 million turnaround from 2023.

Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. "Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter," CEO Benjamin Sze said. "Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower."

Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth

Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.

Ohio's Weed Enthusiasts Help This Cannabis Company's Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA

Cannabis operator with vertical operations in Arizona and Ohio Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Thursday its financial results for the period ended Sept. 30, 2024. "Vext's performance in the third quarter of 2024 was a testament to the team's disciplined execution amid persistent macroeconomic headwinds," Eric Offenberger, CEO of Vext, said. "Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we're pleased to report that our economic unit volumes remain strong."

Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning

The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration.

Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders

Greenlane Cuts Q3 Net Loss Despite 66% Revenue Drop, Shifts Product Strategy

Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion

Cannabis company Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its third quarter 2024 results for the three months ended Sept. 30, 2024. "This was another exciting quarter for Grown Rogue with solid financial metrics showing the continued execution by our team in competitive markets against a backdrop of modest price compression," Obie Strickler, CEO of Grown Rogue, said. "We continue to see strong indoor production yields of craft-quality flower, retail buyer and consumer loyalty, and great initial reception and sell-through with our branded pre-rolls, including our newest brand Yeti".

Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets

C21 Reports Q2 Revenue Up 14% QoQ, South Reno Cannabis Dispensary Sees 53% Sales Growth

Vertically integrated cannabis company C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) announced on Thursday interim unaudited financial statements and management discussion and analysis for its second quarter ending Sept. 30, 2024. "We are pleased with the strong performance and positive customer reception of our new dispensary during its first quarter of operations," Sonny Newman, CEO and president, said. "These results have exceeded our expectations and we continue to see robust sales growth into the new quarter."

Canadian Cannabis Producer Rubicon Reports Record Q3 Revenue Of $13.5M, 34% YoY Growth

Cannabis producer Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) reported on Wednesday its third quarter financial results for the three months ended Sept. 30, 2024. The Vancouver, British Columbia-based company achieved a record net revenue of CA$13.5 million ($9.6 million) for the quarter, representing a 34% increase year-over-year. "Rubicon Organics continues to innovate and expand our product offerings, solidifying a strong market share in premium flower, pre-rolls, edibles, and more," Janis Risbin, the company's CFO, said. "I'm particularly proud of the success of our 2024 vape launch, which has already achieved 55% distribution in just six months. Looking ahead, we expect to drive further growth in Canada and beyond, as we intend for new market entry in 2025."

Cannabis Co. Vireo Reports 2% YoY Revenue Growth, Secures $10M In Financing

Vireo Growth Inc., formerly known as Goodness Growth Holdings, (CSE: VREO) (OTCQX: VREOF) reported on Wednesday financial results for its third quarter ended Sept. 30, 2024. "Our third quarter results reflect continued solid performance across our core markets, but as we discussed anticipating last quarter, year-over-year comparisons of financial performance are less significant now that we have passed the one-year anniversary of the launch of adult-use sales in Maryland," Amber Shimpa, the company's CEO, said. "Our teams continue to focus on preparing for the launch of adult-use sales in Minnesota next year, and our recently announced $10.0 million financing commitment gives us additional flexibility to support this launch and continue executing our CREAM & Fire strategy."

California Cannabis Company Lowell Farms Reports 48% YoY Revenue Decline In Q3

California Cannabis Co. Gold Flora: 241% QoQ Growth In Adjusted EBITDA, Narrows Net Loss By 21%

Vertically integrated California cannabis company Gold Flora Corporation (CBOE: GRAM) (OTCQB: GRAM) announced on Thursday its financial results for the third quarter of fiscal 2024."Amid the ongoing challenges facing the broader industry, we've made significant strides in positioning ourselves for long-term success," Laurie Holcomb, the company's CEO and chairman, said. "We have strengthened our balance sheet through a capital raise, continued scaling the highly successful Gramlin brand, and have further optimized our vertically integrated operations to support our growth initiatives."

Flora Growth Quarterly Revenue Falls 28% YoY As Expenses Rise

Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY

Vertically integrated cannabis multi-state operator Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) reported on Thursday its financial results for the third quarter ended Sept. 30, 2024. "In the third quarter, we continued to focus on re-accelerating growth across our core states, including Connecticut, Illinois, and New Jersey, while also executing on the highly anticipated launch of non-medical sales in Ohio," Dennis Curran, the company's CEO, said. "With our strengthened financial position, we have bolstered our capacity to pursue opportunities in these markets as they continue to mature, which is expected to play a pivotal role in driving both revenue generation and improvements in Adjusted EBITDA as we close out 2024."

TILT Holdings Q3 Revenue Drops 40% YoY Due To Jupiter Hardware Business Challenges

Cannabis Co. 4Front Sees Loss Narrow In Q3, Major Growth In MA, IL

4Front Ventures Q3 2024 results: $17.1M revenue, Illinois expansion, 56% growth in Massachusetts, and new products boost market share.

California Weed Co. Glass House Brands Reports 32% YoY Q3 Revenue Growth (UPDATED)

Vertically integrated cannabis companies Glass House Brands Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) reported on Wednesday financial results for the third quarter ended Sept. 30, 2024. The company is focused on strategic growth initiatives, including expanding production capacity, improving cost efficiency and positioning itself to weather challenges in the California cannabis market. However, retail pricing pressures may continue to affect margins in the near term. "While we expect lower prices to continue in the short-term, longer-term we expect Glass House will benefit, as our Company is built to weather market cycles and emerge even stronger," Kyle Kazan, co-founder, chairman and CEO of Glass House, said.

Agrify's Q3 Revenue Drop, $18.6M Loss Amid New Leadership

Agrify Q3 financial results: $1.9M revenue, $18.6M net loss. New $20M financing and hemp beverage acquisition aim to drive growth.

;